Surgical Treatment in Papillary Thyroid Microcarcinoma
Fatih Tunca1, İsmail Cem Sormaz1, Ahmet Yalın Işcan2, Yasemin Giles Şenyürek11Department of General Surgery, İstanbul University Faculty of Medicine, İstanbul, Turkey2Department of General Surgery, Fatih Sultan Mehmet Training and Research Hospital, İstanbul, Turkey
Despite the notable increasing incidence of papillary thyroid microcarcinoma (PTMC), the optimal treatment of the patients with PTMC remains controversial. Because of no consensus about its treatment, the suggested treatment varies from active surveillance alone to total thyroidectomy. Although the 2015 revised American Thyroid Association guideline recommends hemithyroidectomy as the first-line treatment, active surveillance has also been discussed and accepted as another approach for the patients with PTMC. However, the same guideline does not recommend fine needle aspiration biopsy for nodules sized <1 cm, even it is suspicious. In such situation, neither active surveillance nor hemithyroidectomy could be discussed, with a lack of objective cytologic data about the nodules sized <1 cm. In this situation, the decision to perform FNAB to the nodules <1 cm in size depends on the performer of the thyroid ultrasonography.
In this invited review, we have discussed the diagnosis and prognostic factors for PTMCs. We have also discussed surgical strategies as the accepted the first-line treatment in patients with PTMC.
Surgical Treatment in Papillary Thyroid Microcarcinoma
Fatih Tunca1, İsmail Cem Sormaz1, Ahmet Yalın Işcan2, Yasemin Giles Şenyürek11Department of General Surgery, İstanbul University Faculty of Medicine, İstanbul, Turkey2Department of General Surgery, Fatih Sultan Mehmet Training and Research Hospital, İstanbul, Turkey
Despite the notable increasing incidence of papillary thyroid microcarcinoma (PTMC), the optimal treatment of the patients with PTMC remains controversial. Because of no consensus about its treatment, the suggested treatment varies from active surveillance alone to total thyroidectomy. Although the 2015 revised American Thyroid Association guideline recommends hemithyroidectomy as the first-line treatment, active surveillance has also been discussed and accepted as another approach for the patients with PTMC. However, the same guideline does not recommend fine needle aspiration biopsy for nodules sized <1 cm, even it is suspicious. In such situation, neither active surveillance nor hemithyroidectomy could be discussed, with a lack of objective cytologic data about the nodules sized <1 cm. In this situation, the decision to perform FNAB to the nodules <1 cm in size depends on the performer of the thyroid ultrasonography.
In this invited review, we have discussed the diagnosis and prognostic factors for PTMCs. We have also discussed surgical strategies as the accepted the first-line treatment in patients with PTMC.
Manuscript Language: English